Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ)
CNY 17.47
(0.17%)
CNY 17.47
(0.17%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 49.15 Million CNY | -75.86% |
| 2022 | 203.59 Million CNY | 358.99% |
| 2021 | 44.35 Million CNY | -68.65% |
| 2020 | 141.5 Million CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 5.38 Million CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 6.71 Million CNY | 38.77% |
| 2015 | 4.84 Million CNY | 0.0% |
| 2014 | - CNY | -100.0% |
| 2013 | 1 Million CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 31.89 Million CNY | -59.7% |
| 2024 Q1 | 28.96 Million CNY | -41.08% |
| 2024 Q2 | 48.86 Million CNY | 68.73% |
| 2023 Q2 | 225.01 Million CNY | 2.66% |
| 2023 FY | 49.15 Million CNY | -75.86% |
| 2023 Q1 | 219.19 Million CNY | 7.66% |
| 2023 Q4 | 49.15 Million CNY | -70.93% |
| 2023 Q3 | 169.1 Million CNY | -24.85% |
| 2022 FY | 203.59 Million CNY | 358.99% |
| 2022 Q4 | 203.59 Million CNY | 406.38% |
| 2022 Q3 | 40.2 Million CNY | 2.21% |
| 2022 Q2 | 39.33 Million CNY | -42.16% |
| 2022 Q1 | 68 Million CNY | 53.31% |
| 2021 FY | 44.35 Million CNY | -68.65% |
| 2021 Q4 | 44.35 Million CNY | 47.86% |
| 2021 Q3 | 30 Million CNY | -39.26% |
| 2021 Q1 | 60 Million CNY | -57.6% |
| 2021 Q2 | 49.39 Million CNY | -17.68% |
| 2020 Q3 | 141.5 Million CNY | 0.0% |
| 2020 FY | 141.5 Million CNY | 0.0% |
| 2020 Q1 | 81.28 Million CNY | 0.0% |
| 2020 Q2 | 141.5 Million CNY | 74.09% |
| 2020 Q4 | 141.5 Million CNY | 0.0% |
| 2019 Q1 | 5.38 Million CNY | 0.0% |
| 2019 Q2 | 2.78 Million CNY | -48.26% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q3 | - CNY | -100.0% |
| 2019 FY | - CNY | -100.0% |
| 2018 Q3 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 FY | 5.38 Million CNY | 0.0% |
| 2018 Q4 | 5.38 Million CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 FY | 6.71 Million CNY | 38.77% |
| 2016 Q3 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2016 Q1 | - CNY | 0.0% |
| 2015 Q3 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 FY | 4.84 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 FY | - CNY | -100.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2013 Q3 | 1 Million CNY | 0.0% |
| 2013 Q4 | 1 Million CNY | 0.0% |
| 2013 FY | 1 Million CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |